Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from Faes Farma ( (ES:FAE) ).
Faes Farma, S.A. has announced the convening of its General Shareholders’ Meeting, scheduled for June 24 or 25, 2025, to discuss and approve key financial and management reports for the 2024 fiscal year. The meeting will also address the appointment of a new independent director and include an advisory vote on the directors’ remuneration report, reflecting the company’s ongoing governance and strategic planning efforts.
More about Faes Farma
Faes Farma, S.A. operates in the pharmaceutical industry, focusing on the development, production, and commercialization of pharmaceutical products. The company is known for its commitment to innovation and sustainability in its operations.
YTD Price Performance: 23.44%
Average Trading Volume: 912,611
Technical Sentiment Signal: Buy
Current Market Cap: €1.33B
For a thorough assessment of FAE stock, go to TipRanks’ Stock Analysis page.